We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+22.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$68.5B
AUM Growth
+$9.41B
Cap. Flow
-$1.48B
Cap. Flow %
-2.16%
Top 10 Hldgs %
11.5%
Holding
2,417
New
97
Increased
651
Reduced
820
Closed
64

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$694M
2
BNY
Bank of New York Mellon
BNY
+$668M
3
MRSH
Marsh
MRSH
+$609M
4
DIS icon
Walt Disney
DIS
+$140M
5
TFC icon
Truist Financial
TFC
+$128M

Sector Composition

Rank Sector Weight
1 Technology 18.62%
2 Healthcare 15.47%
3 Financials 13.03%
4 Industrials 11.38%
5 Consumer Discretionary 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YUMC icon
926
Yum China
YUMC
$15.6B
$3.5M 0.01%
61,341
-18,160
-23% -$1.02M
LMND icon
927
Lemonade
LMND
$4.77B
$3.47M 0.01%
+28,327
New +$2.09M
DVA icon
928
DaVita
DVA
$15.4B
$3.46M 0.01%
29,503
+7,170
+32% +$730K
LITE icon
929
Lumentum
LITE
$50.7B
$3.45M 0.01%
36,370
-2,355
-6% -$203K
IEFA icon
930
iShares Core MSCI EAFE ETF
IEFA
$187B
$3.42M 0.01%
+49,574
New +$3.21M
JBL icon
931
Jabil
JBL
$31.7B
$3.42M 0.01%
80,529
PAYX icon
932
Paychex
PAYX
$42.3B
$3.42M 0.01%
36,740
+2,279
+7% +$202K
DVAX
933
DELISTED
Dynavax Technologies
DVAX
$3.4M 0.01%
763,724
EDU icon
934
New Oriental
EDU
$8.08B
$3.37M ﹤0.01%
18,113
-15,983
-47% -$2.69M
WPF
935
DELISTED
Foley Trasimene Acquisition Corp.
WPF
$3.35M ﹤0.01%
+300,000
New +$3.12M
EBAY icon
936
eBay
EBAY
$52.1B
$3.34M ﹤0.01%
66,458
+38,706
+139% +$1.98M
PCG icon
937
PG&E
PCG
$39.2B
$3.32M ﹤0.01%
266,205
+72,599
+37% +$821K
SPXC icon
938
SPX Corp
SPXC
$10.2B
$3.31M ﹤0.01%
60,673
-12,675
-17% -$636K
PD icon
939
PagerDuty
PD
$795M
$3.31M ﹤0.01%
79,336
-6,290
-7% -$214K
ESI icon
940
Element Solutions
ESI
$8.89B
$3.3M ﹤0.01%
186,056
-14,104
-7% -$195K
SLB icon
941
SLB Ltd
SLB
$74.2B
$3.29M ﹤0.01%
150,968
+32,842
+28% +$620K
CAKE icon
942
Cheesecake Factory
CAKE
$4.42B
$3.27M ﹤0.01%
88,118
+87,216
+9,669% +$2.99M
SLG icon
943
SL Green Realty
SLG
$3.77B
$3.25M ﹤0.01%
53,058
+2,716
+5% +$144K
GSHD icon
944
Goosehead Insurance
GSHD
$1.63B
$3.25M ﹤0.01%
26,069
-7,841
-23% -$896K
FE icon
945
FirstEnergy
FE
$28.7B
$3.25M ﹤0.01%
106,117
+12,148
+13% +$364K
RCKT icon
946
Rocket Pharmaceuticals
RCKT
$343M
$3.25M ﹤0.01%
59,174
FMTX
947
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$3.24M ﹤0.01%
92,786
SURF
948
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$3.23M ﹤0.01%
+350,000
New +$3.04M
UHS icon
949
Universal Health Services
UHS
$10.1B
$3.22M ﹤0.01%
23,419
+200
+0.9% +$24.9K
MDGL icon
950
Madrigal Pharmaceuticals
MDGL
$12.4B
$3.2M ﹤0.01%
28,820

Similar funds

Macquarie Group's Q4 2020 Portfolio in Review

As of Q4 2020, Macquarie Group held 2,417 positions worth $68.5B, up 16% from $59.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group's Q4 2020 filing shows 97 new, 651 increased, 820 reduced and 64 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M. The largest sale was Pfizer, an estimated $694M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Macquarie Group's largest Q4 2020 buy was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M.
  • Macquarie Group added most to Discover Financial Services in Q4 2020, an estimated $613M increase.
  • Macquarie Group's biggest Q4 2020 reduction was Pfizer, cutting an estimated $694M.
  • Macquarie Group fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $64.8M.
  • Macquarie Group's ten largest holdings make up 11% of its $68.5B portfolio in Q4 2020.
  • Macquarie Group opened 97 new positions and closed 64 in Q4 2020.
  • Macquarie Group's portfolio value rose 16% quarter-over-quarter to $68.5B.

Based on Macquarie Group's 13F filing for Q4 2020, filed 16 Feb 2021.